The health risk of chrysotile asbestos

Current Opinion in Pulmonary Medicine

Volumn 20, Issue 4, 2014, Pages 366-370

  Bernstein, David M ^a  

^a Consultant in Toxicology ^*  (Switzerland)

Author keywords

amphibole asbestos; biopersistence; chrysotile; epidemiology; inhalation toxicology; lung; pleura

Indexed keywords

AMOSITE; AMPHIBOLE; CHRYSOTILE; CROCIDOLITE; AIR POLLUTANT; MINERAL FIBER;

BIOPERSISTENCE; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; ETIOLOGY; FIBROSING ALVEOLITIS; HEALTH HAZARD; HUMAN; IN VITRO STUDY; INDUSTRIAL HYGIENE; LUNG; LUNG ALVEOLUS MACROPHAGE; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; PLEURA CAVITY; REVIEW; TOXIC INHALATION; AIR POLLUTANT; ASBESTOSIS; CHEMICALLY INDUCED; EXPOSURE; OCCUPATIONAL DISEASE; PATHOLOGY; RISK; TOXICITY;

AIR POLLUTANTS, OCCUPATIONAL; ASBESTOS, AMPHIBOLE; ASBESTOS, SERPENTINE; ASBESTOSIS; HUMANS; INHALATION EXPOSURE; LUNG; MINERAL FIBERS; OCCUPATIONAL DISEASES; RISK;

EID: 84901831537     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000064     Document Type: Review

References (54)

1. Kobell F. Ueber den schillernden Asbest von Reichenstein in Schlesien. J Prakt Chemie 1834; 2:297-298.
2. Whittaker EJW. The Structure of chrysotile. V. Diffuse reflexions and fibre texture. Acta Cryst 1957; 10:149-156.
3. Whittaker EJW. In Research report: chrysotile fibers-filled or hollow tubes? Mathematical interpretation may resolve conflicting evidence. Chem Eng News 1963; 41:34-35.
4. Tanji T, Yada K, Akatsuka Y. Alternation of clino-and orthochrysotile in a single fiber as revealed by high-resolution electron microscopy. Clay Clay Miner 1984; 32:429-432.
5. Titulaer MK, van Miltenburg JC, Jansen JBH, et al. Characterization of tubular chrysotile by thermoporometry, nitrogen sorption, drifts, and TEM. Clays Clay Miner 1993; 41:496-513.
6. Skinner HCW, Ross M, Frondel C. Asbestos and other fibrous materials-mineralogy, crystal chemistry, and health effects. New York (NY): Oxford University Press; 1988. p. 204.
7. Whittaker EJW. The crystal chemistry of the amphiboles. Acta Cryst 1960; 13:291-298.
8. Speil S, Leineweber JP. Asbestos minerals in modern technology. Environ Res 1969; 2:166-208.
9. Fels AOS, Cohn ZA. The alveolar macrophage. J Appl Physiol 1986; 60:353-369.
10. Bernstein DM. Synthetic vitreous fibers: a review of toxicology, epidemiology and regulations. Crit Rev Toxicol 2007; 37:839-886.
11. Bernstein DM, Rogers RA, Sepulveda R, et al. Quantification of the pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite-asbestos following short-term inhalation exposure. Inhal Toxicol 2011; 23:372-391.
12. Bernstein D, Dunnigan J, Hesterberg T, et al. Health risk of chrysotile revisited. Crit Rev Toxicol 2013; 43:154-183.
13. Qi F, Okimoto G, Jube S, et al. Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-a signaling. Am J Pathol 2013; 183:1654-1666.
14. Okayasu R, Wu L, Hei TK. Biological effects of naturally occurring and man-made fibres: in vitro cytotoxicity and mutagenesis in mammalian cells. Br J Cancer 1999; 79:319-324.
15. Bernstein D, Castranova V, Donaldson K, et al. Testing of fibrous particles: short-term assays and strategies. Inhal Toxicol 2005; 17:497-537.
16. Guldberg M, Jensen SL, Knudsen T, et al. High-alumina low-silica HT stone wool fibers: a chemical compositional range with high biosolubility. Regul Toxicol Pharmacol 2002; 35 (2 Pt 1):217-226.
17. Suquet H. Effects of dry grinding and leaching on the crystal structure of chrysotile. Clays Clay Miner 1989; 37:439-445.
18. Bernstein DM, Rogers R, Smith P. The biopersistence of Canadian chrysotile asbestos following inhalation. Inhal Toxicol 2003; 15:101-128.
19. Bernstein DM, Rogers R, Smith P. The biopersistence of Brazilian chrysotile asbestos following inhalation. Inhal Toxicol 2004; 16:745-761.
20. Bernstein DM, Rogers R, Smith P. The biopersistence of Canadian chrysotile asbestos following inhalation: final results through 1 year after cessation of exposure. Inhal Toxicol 2005; 17:1-14.
21. Bernstein DM, Chevalier J, Smith P. Comparison of Calidria chrysotile asbestos to pure tremolite: final results of the inhalation biopersistence and histopathol-ogy following short term exposure. Inhal Toxicol 2005; 17:427-449.
22. Bernstein DM, Rogers R, Sepulveda R, et al. Evaluation of the deposition, translocation and pathological response of brake dust with and without added chrysotile in comparison to crocidolite asbestos following short-term inhalation: Interim results. Toxicol Appl Pharmacol 2014; 276:28-46.
23. Bolton RE, Vincent JH, Jones AD, et al. An overload hypothesis for pulmonary clearance of UICC amosite fibres inhaled by rats. Br J Ind Med 1983; 40:264-272.
24. Muhle H, Bellman B, Heinrich U. Overloading of lung clearance during chronic exposure of experimental animals to particles. Ann Occup Hyg 1988; 32:141-147.
25. Morrow PE. Possible mechanisms to explain dust overloading of the lung. Fundam Appl Toxicol 1988; 10:369-384.
26. Oberdorster G. Lung particle overload: implications for occupational exposures to particles. Regul Toxicol Pharmacol 1995; 21:123-135.
27. ILSI Risk Science Institute. The relevance of the rat lung response to particle overload for human risk assessment: a workshop consensus report. Inhal Toxicol 2000; 12:1-17.
28. Timbrell V, Hyett AW, Skidmore JW. A simple dispenser for generating dust clouds from standard reference samples of asbestos. Ann Occup Hyg 1968; 11:273-281.
29. Timbrell V, RendallREG. Preparation of the UICC standard reference samples of asbestos. Powder Technol 1972; 5:279-287.
30. Pinkerton KE, Brody AR, McLaurin DA, et al. Characterization of three types of chrysotile asbestos after aerosolization. Environ Res 1983; 31:32-53.
31. Campbell WJ, Huggins CW, Wylie AG. Chemical and physical characterization of amosite, chrysotile, crocidolite, and nonfibrous tremolite for oral ingestion studies by the National Institute of Environmental Health Sciences [report of investigation 8452]. Avondale (MD): United States Department of The Interior, US Bureau of Mines; 1980.
32. Bernstein DM, Rogers R, Chevalier J, et al. The toxicological response of Brazilian chrysotile asbestos: a multidose sub-chronic 90 d inhalation toxicology study with 92 day recovery to assess cellular and pathological response. Inhal Toxicol 2006; 18:313-332.
33. Berman DW, Crump KS. Draft technical support document for a protocol to assess asbestos-related risk. Washington, DC: 20460: Office of Solid Waste and Emergency Response U.S. Environmental Protection Agency; 2003.
34. Ashcroft T. Epidemiological and quantitative relationships between mesothelioma and asbestos on Tyneside. J Clin Pathol 1973; 26:832-840.
35. Elmes PC, Wade OL Relationship between exposure to asbestos and pleural malignancy in Belfast. Ann N Y Acad Sci 1965; 132:549-557.
36. Hain E, Dalquen P, Bohlig H, et al. Retrospective study of 150 cases of mesothelioma in Hamburg area (author's transl). Int Arch Arbeitsmed 1974; 33:15-37.
37. McDonald AD, Harper A, McDonald JC, et al. Epidemiology of primary malignant mesothelial tumors in Canada. Cancer 1970; 26:914-919.
38. McEwen J, Finlayson A, Mair A, et al. Mesothelioma in Scotland. Br Med J 1970; 4:575-578.
39. Newhouse ML, Thompson H. Mesothelioma of pleura and peritoneum following exposure to asbestos in the London area. Br J Ind Med 1965; 22:261-269.
40. Rubino GF, Scansetti G, Donna A, et al. Epidemiology of pleural mesothelioma in North-western Italy (Piedmont). Br J Ind Med 1972; 29:436-442.
41. Zielhuis RL, Versteeg JP, Planteijdt HT. Pleura mesothelioma and exposure to asbestos: a retrospective case-control study in the Netherlands. Int Arch Occup Environ Health 1975; 36:1-18.
42. Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000; 44:565-601.
43. Dement JM, Brown DP. Lung cancer mortality among asbestos textile workers: a review and update. Ann Occup Hyg 1994; 38:525-532.
44. McDonald AD, Fry JS, Woolley AJ, McDonald JC. Dust exposure and mortality in an American factory using chrysotile, amosite, and crocidolite in mainly textile manufacture. Br J Ind Med 1983; 40:368-374.
45. Piolatto G, Negri E, La Vecchia C, et al. An update of cancer mortality among chrysotile asbestos miners in Balangero, northern Italy. Br J Ind Med 1990; 47:810-814.
46. Liddell FDK, McDonald AD, McDonald JC. Dust exposure and lung cancer in Quebec chrysotile miners and millers. Ann Occup Hyg 1998; 42:7-20.
47. Hughes JM, Weill H, Hammad YY. Mortality of workers employed in two asbestos cement manufacturing plants. Br J Ind Med 1998; 44:161-174.
48. McDonald AD, Fry JS, Woolley AJ, McDonald JC. Dust exposure and mortality in an American chrysotile asbestos friction products plant. Br J Ind Med 1984; 41:151-157.
49. Weill H, Hughes J, Waggenspack C. Influence of dose and fiber type on respiratory malignancy risk in asbestos cement manufacturing. Am Rev Respir Dis 1979; 120:345-354.
50. Thomas HF, Benjamin IT, Elwood PC, et al. Further follow-up study of workers from an asbestos cement factory. Br J Ind Med 1982; 39:273-276.
51. Gardner MJ, Winter PD, Pannett B, et al. Follow up study of workers manufacturing chrysotile asbestos cement products. Br J Ind Med 1986; 43:726-732.
52. Ohlson CG, Hogstedt C. Lung cancer among asbestos cement workers. A Swedish cohort study and a review. Br J Ind Med 1985; 42:397-402.
53. Sichletidis L, Chloros D, Spyratos D, et al. Mortality from occupational exposure to relatively pure chrysotile: a 39-year study. Respiration 2009; 78:63-68.
54. Yano E, Wang ZM, Wang XR, et al. Cancer mortality among workers exposed toamphibole-free chrysotile asbestos. Am J Epidemiol 2001; 154:538-543.